{"name":"Joon Bum Kim","slug":"joon-bum-kim","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Vitamin K antagonist(warfarin)","genericName":"Vitamin K antagonist(warfarin)","slug":"vitamin-k-antagonist-warfarin","indication":"Atrial fibrillation for stroke prevention","status":"marketed"}]}],"pipeline":[{"name":"Vitamin K antagonist(warfarin)","genericName":"Vitamin K antagonist(warfarin)","slug":"vitamin-k-antagonist-warfarin","phase":"marketed","mechanism":"Warfarin inhibits vitamin K-dependent clotting factors (II, VII, IX, X) by blocking the vitamin K epoxide reductase enzyme, thereby reducing thrombin generation and blood clot formation.","indications":["Atrial fibrillation for stroke prevention","Venous thromboembolism (deep vein thrombosis and pulmonary embolism) treatment and prevention","Mechanical heart valve thromboprophylaxis","Acute myocardial infarction with high thromboembolic risk"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE9sWkR2QW9OZmF6SWQwQS02NjZVS0VESGxiU0hSR3pwN0FZVUUwZ3djcm1qLVljZlpqSUI5aHNCM1o2TGFlckxmaWVLaXJTTHNLb1pxOHI4bndsVEgyeFRXc1Rqdw?oc=5","date":"2024-10-10","type":"pipeline","source":"매일경제","summary":"Actors Oh Seung-hoon, Han Eun-sung, Lee Woo-tae, Kim Jun-bum, and Hong Jong-hyun will star in Findin.. - 매일경제","headline":"Actors Oh Seung-hoon, Han Eun-sung, Lee Woo-tae, Kim Jun-bum, and Hong Jong-hyun will star in Findin.. - 매일경제","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9nZDl6c1IyX2J6Q0Y5ZGtFc0lGSW9qSDktTUlIdHVuRW9BWTlVR1gwNjVramNFVFNMZkwwNWxNSUJGZnBaZkhaWGJER09sbHJjVGtV?oc=5","date":"2016-07-01","type":"pipeline","source":"Nature","summary":"Inhibition of HIV-1 reactivation by a telomerase-derived peptide in a HSP90-dependent manner - Nature","headline":"Inhibition of HIV-1 reactivation by a telomerase-derived peptide in a HSP90-dependent manner","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTFBQaExVanNyUjMyamlJTElIbFhIZTVVS2pBZDg0Zzd5cUVra0I1cVRJTXBYRzkxQXk3cUVONmVlZVFpQWdOUE5zaU9HT2M2c3hhdk03NDZmNzlnUmtqOXlHZjFVbjdpdkx1MzRGaWNQN1B3Zw?oc=5","date":"2015-01-14","type":"pipeline","source":"Businesskorea","summary":"Local Botulinum Toxin Formula Reportedly Better than Botox - Businesskorea","headline":"Local Botulinum Toxin Formula Reportedly Better than Botox","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}